Be Prepared to Dispense Meds for COPD

November 2023

You’ll see more focus on optimizing treatment for patients with COPD...due to updated Canadian guidelines.

Expect pharmacists to ask about the patient’s symptoms and exacerbation history to help guide recommendations.

For example, patients with mild symptoms and LOW risk of exacerbations will start with a long-acting beta-agonist (Serevent, etc) OR a long-acting muscarinic antagonist (Spiriva, etc).

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote